Bruck Kifle

Array ( [id] => 83720 [patent_doc_number] => 07741319 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-22 [patent_title] => '11-hydroxy-5h-pyrrolo[2,1-c][1,4] benzodiazepin-5-one derivatives as key intermediates for the preparation of c2 substituted pyrrolobenzodiazepines' [patent_app_type] => utility [patent_app_number] => 10/598518 [patent_app_country] => US [patent_app_date] => 2005-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24396 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/741/07741319.pdf [firstpage_image] =>[orig_patent_app_number] => 10598518 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5070247 [patent_doc_number] => 20070191349 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'C8, c8\' linked 5-oxo-1,2,3,11a-tetrahydro-5h-pyrrolo[2,1-c][1,4] benzodiazepine dimers with 1h-pyrrole-dicarboxylic acid amide linkers and oligomeric analogs therof as well as related compounds for the treatment of proliferative diseases' [patent_app_type] => utility [patent_app_number] => 10/598470 [patent_app_country] => US [patent_app_date] => 2005-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29458 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20070191349.pdf [firstpage_image] =>[orig_patent_app_number] => 10598470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 517631 [patent_doc_number] => 07193078 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-03-20 [patent_title] => 'Process for production of O-alkylated rapamycin derivatives' [patent_app_type] => utility [patent_app_number] => 11/067718 [patent_app_country] => US [patent_app_date] => 2005-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3133 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/193/07193078.pdf [firstpage_image] =>[orig_patent_app_number] => 11067718 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7075323 [patent_doc_number] => 20050148591 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => 'Tartrate salts of 5,8,14-triazatetracyclo [10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaen and pharmaceutical compositions thereof' [patent_app_type] => utility [patent_app_number] => 11/069724 [patent_app_country] => US [patent_app_date] => 2005-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 15929 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20050148591.pdf [firstpage_image] =>[orig_patent_app_number] => 11069724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7075307 [patent_doc_number] => 20050148575 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => 'Compounds and their uses' [patent_app_type] => utility [patent_app_number] => 11/066478 [patent_app_country] => US [patent_app_date] => 2005-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 44004 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20050148575.pdf [firstpage_image] =>[orig_patent_app_number] => 11066478 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6945330 [patent_doc_number] => 20050197379 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-08 [patent_title] => 'Macrolides and methods for producing same' [patent_app_type] => utility [patent_app_number] => 11/065934 [patent_app_country] => US [patent_app_date] => 2005-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6853 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20050197379.pdf [firstpage_image] =>[orig_patent_app_number] => 11065934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 204680 [patent_doc_number] => 07629294 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-08 [patent_title] => 'Pyrazolopyrimidines' [patent_app_type] => utility [patent_app_number] => 11/063191 [patent_app_country] => US [patent_app_date] => 2005-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49135 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/629/07629294.pdf [firstpage_image] =>[orig_patent_app_number] => 11063191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7256791 [patent_doc_number] => 20050143401 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Anilinoquinazaolines as protein tyrosine kianse inhibitors' [patent_app_type] => utility [patent_app_number] => 11/061578 [patent_app_country] => US [patent_app_date] => 2005-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43584 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20050143401.pdf [firstpage_image] =>[orig_patent_app_number] => 11061578 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 702248 [patent_doc_number] => 07064200 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-20 [patent_title] => 'Process for the synthesis of 1,3,4,5-tetrahydro-2H-3-benzazepin-2-one compounds, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid' [patent_app_type] => utility [patent_app_number] => 11/060043 [patent_app_country] => US [patent_app_date] => 2005-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1169 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/064/07064200.pdf [firstpage_image] =>[orig_patent_app_number] => 11060043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 691534 [patent_doc_number] => 07074920 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-11 [patent_title] => 'Process for the synthesis of 1,3-dihydro-2H-3-benzazepin-2-one compounds, and to the application thereof in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid' [patent_app_type] => utility [patent_app_number] => 11/057491 [patent_app_country] => US [patent_app_date] => 2005-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1477 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/074/07074920.pdf [firstpage_image] =>[orig_patent_app_number] => 11057491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 535500 [patent_doc_number] => 07176197 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-13 [patent_title] => 'Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid' [patent_app_type] => utility [patent_app_number] => 11/057492 [patent_app_country] => US [patent_app_date] => 2005-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2359 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/176/07176197.pdf [firstpage_image] =>[orig_patent_app_number] => 11057492 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 745858 [patent_doc_number] => 07026474 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-11 [patent_title] => 'Method for producing ε-caprolactam and method for reactivating catalyst for production of ε-caprolactam' [patent_app_type] => utility [patent_app_number] => 11/055101 [patent_app_country] => US [patent_app_date] => 2005-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3383 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/026/07026474.pdf [firstpage_image] =>[orig_patent_app_number] => 11055101 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 638939 [patent_doc_number] => RE039356 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2006-10-17 [patent_title] => 'Process for the preparation of epothilone analogs' [patent_app_type] => reissue [patent_app_number] => 11/056606 [patent_app_country] => US [patent_app_date] => 2005-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6255 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/039/RE039356.pdf [firstpage_image] =>[orig_patent_app_number] => 11056606 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 840468 [patent_doc_number] => 07390798 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-24 [patent_title] => 'Carboxamide spirolactam CGRP receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/660798 [patent_app_country] => US [patent_app_date] => 2005-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19058 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/390/07390798.pdf [firstpage_image] =>[orig_patent_app_number] => 11660798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7098498 [patent_doc_number] => 20050130957 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Novel substituted pyrazolo[4,3-e]diazepines, pharmaceutical compositions containing them, use as medical products and processes for preparing them' [patent_app_type] => utility [patent_app_number] => 11/050526 [patent_app_country] => US [patent_app_date] => 2005-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45629 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20050130957.pdf [firstpage_image] =>[orig_patent_app_number] => 11050526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5253999 [patent_doc_number] => 20070135455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Substituted thieno- and thiazolo- [2,3-d]pyrimidines and [2,3-c]pyridines as inhibitors of tie2' [patent_app_type] => utility [patent_app_number] => 10/588621 [patent_app_country] => US [patent_app_date] => 2005-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11210 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20070135455.pdf [firstpage_image] =>[orig_patent_app_number] => 10588621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 352691 [patent_doc_number] => 07491713 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-17 [patent_title] => 'CGRP receptor antagonists' [patent_app_type] => utility [patent_app_number] => 10/587121 [patent_app_country] => US [patent_app_date] => 2005-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25244 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/491/07491713.pdf [firstpage_image] =>[orig_patent_app_number] => 10587121 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 467640 [patent_doc_number] => 07235541 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-26 [patent_title] => 'Neurokinin antagonists for use as medicaments' [patent_app_type] => utility [patent_app_number] => 11/042752 [patent_app_country] => US [patent_app_date] => 2005-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14660 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/235/07235541.pdf [firstpage_image] =>[orig_patent_app_number] => 11042752 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7111754 [patent_doc_number] => 20050209210 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Rifamycin imino derivatives effective against drug-resistant microbes' [patent_app_type] => utility [patent_app_number] => 11/034279 [patent_app_country] => US [patent_app_date] => 2005-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 23733 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 47 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20050209210.pdf [firstpage_image] =>[orig_patent_app_number] => 11034279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 453207 [patent_doc_number] => 07247634 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-24 [patent_title] => 'Rifamycin derivatives effective against drug-resistant microbes' [patent_app_type] => utility [patent_app_number] => 11/034195 [patent_app_country] => US [patent_app_date] => 2005-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 29015 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 49 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/247/07247634.pdf [firstpage_image] =>[orig_patent_app_number] => 11034195 [rel_patent_id] =>[rel_patent_doc_number] =>)